Cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item Thumbnail image Product Price Quantity Subtotal
× Placeholder The Risks of Prescribing Hydroxychloroquine in COVID-19-Infected Patients With Schizophrenia PDF $40.00
$40.00
× Placeholder Eyelash Loss Secondary to Escitalopram But Not to Sertraline: A Case Report PDF $40.00
$40.00
× Placeholder The Effects of Olanzapine in Reducing the Emergence of Psychosis Among Nursing Home Patients With Alzheimer's Disease PDF $40.00
$40.00
× Placeholder Continued Cannabis Use and Outcome in First-Episode Psychosis: Data From a Randomized, Open-Label, Controlled Trial PDF $40.00
$40.00
× Placeholder Effectiveness of Brief Cognitive-Behavioral Therapy for Schizophrenia Delivered by Mental Health Nurses: Relapse and Recovery at 24 Months PDF $40.00
$40.00
× Placeholder Pharmacologic Treatment of Dimensional Anxious Depression: A Review PDF $40.00
$40.00
× Placeholder Clozapine Augmentation With Antiepileptic Drugs for Treatment-Resistant Schizophrenia: A Meta-Analysis of Randomized Controlled Trials PDF $40.00
$40.00
× Placeholder Treating Nicotine Dependence by Targeting Attention-Deficit/ Hyperactivity Disorder (ADHD) With OROS Methylphenidate: The Role of Baseline ADHD Severity and Treatment Response PDF $40.00
$40.00
× Placeholder Patient Health Questionnaire Depression Scale as a Suicide Screening Instrument in Depressed Primary Care Patients: A Cross-Sectional Study PDF $40.00
$40.00

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.


Join Now

Cart totals

Subtotal $360.00
Total $360.00